Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details Narrative)

v3.20.4
Income Taxes (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Research and development tax credit carryforwards $ 1,263,451 $ 294,707
Valuation allowance 4,900,000 1,400,000
Income tax expense (benefit)
Federal [Member]    
Operating loss carryovers $ 24,500,000  
Operating loss carryforwards expiration period 2035  
Research and development tax credit carryforwards $ 700,000  
Tax credit carryforwards for reduce future tax liabilities period, description 2035  
New Jersey [Member]    
Operating loss carryovers $ 24,500,000  
Operating loss carryforwards expiration period 2035  
Research and development tax credit carryforwards $ 500,000  
Tax credit carryforwards for reduce future tax liabilities period, description 2030  
Foreign [Member]    
Operating loss carryovers $ 15,000,000  
Operating loss carryforwards expiration period 2027